Closing the Gap in Care in Seronegative Inflammatory Arthritis

PsA Clinical Trial

— Metrix II  

Official title:

Closing the Gap in Care in Seronegative Inflammatory Arthritis: From Identification to Implementation of Treating to Target: A Randomized Trial of Feedback, Education, and Behavioural Change

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01749618
• Other study ID #: Metrix II
• Status: Completed
• Phase: N/A
• First received: November 6, 2012
• Last updated: April 5, 2017
• Start date: November 2012
• Est. completion date: November 2016

Study information

• Verified date: April 2017
• Source: Pope Research Corporation
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: November 2016
• Est. primary completion date: November 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Canadian Rheumatologist

Exclusion Criteria:

Related Conditions & MeSH terms

• Arthritis
• PsA
• SpA

Intervention

Behavioral:
• Education and Feedback
Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.

Locations

Country	Name	City	State
Canada	Dr. Vandana Ahluwalia	Brampton	Ontario
Canada	Dr. Sanjay Dixit	Burlington	Ontario
Canada	Dr Pauline Boulos	Hamilton	Ontario
Canada	Dr. Nikhil Chopra	London	Ontario
Canada	Credit Valley Rheumatology	Mississauga	Ontario
Canada	Dr Angela Montgomery	Mississauga	Ontario
Canada	The Medical Centre	Peterborough	Ontario
Canada	Dr. Arthur Karasik	Toronto	Ontario
Canada	Sunnybrook Health Sciences Centre	Toronto	Ontario

Sponsors (3)

Lead Sponsor	Collaborator
Pope Research Corporation	Abbott, Academic Medical Organization of Southwestern Ontario

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement of Systematic Assessments	Physicians in the Education and Feedback arm are assessed via a needs assessment to identify the care gaps for their patients with inflammatory arthritis. After the education and feedback, they complete a second chart audit and their improvements in assessments is recorded.	November 2012 - November 2013